¼¼°èÀÇ ¸»ÃÊ ÀÎÅͺ¥¼Ç ½ÃÀå
Peripheral Interventions
»óǰÄÚµå : 1795826
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 492 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸»ÃÊ ÀÎÅͺ¥¼Ç ¼¼°è ½ÃÀåÀº 2030³â±îÁö 163¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 108¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸»ÃÊ ÀÎÅͺ¥¼Ç ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 7.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 163¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾ÆÅ×·ºÅä¹Ì ÀÎÅͺ¥¼ÇÀº CAGR 5.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 65¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ºÅÙÆ® À¯Ä¡ ÀÎÅͺ¥¼Ç ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 29¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸»ÃÊ ÀÎÅͺ¥¼Ç ½ÃÀåÀº 2024³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 34¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 10.9%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.7%¿Í 6.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¸»ÃÊ ÀÎÅͺ¥¼Ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¸»ÃÊÇ÷°ü ÁßÀç¼úÀÌ ÃֽŠÇ÷°ü Ä¡·á¹ýÀ¸·Î °¢±¤¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

½ÉÀåÀ̳ª ³ú ÀÌ¿ÜÀÇ Ç÷°üÀÇ ¸·ÈûÀ̳ª ÀÌ»óÀ» Ä¡·áÇÏ´Â ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÎ ¸»ÃÊÁßÀç¼úÀº ¸¸¼º Ç÷°ü ÁúȯÀÌ Àü ¼¼°èÀûÀ¸·Î È®´ëµÊ¿¡ µû¶ó Ç÷°ü Ä¡·áÀÇ ÇʼöÀûÀÎ ºÎºÐÀ¸·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. Ç÷°ü¼ºÇü¼ú, ½ºÅÙÆ®»ðÀÔ¼ú, µ¿¸ÆÀýÁ¦¼ú, Ç÷ÀüÁ¦°Å¼ú, »öÀü¼ú, Á¤¸Æ ³» ¼ÒÀÛ¼ú µîÀÌ ÀÖ½À´Ï´Ù. À̵éÀº ¸»Ãʵ¿¸ÆÁúȯ(PAD), ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT), Á¤¸Æ·ù, µ¿¸Æ·ù, µ¿Á¤¸Æ ±âÇü µîÀ» °ü¸®Çϱâ À§ÇØ »ç¿ëµË´Ï´Ù.

°í·ÉÈ­, ´ç´¢º´, Èí¿¬, ÁÂ½Ä »ýȰ½À°ü µîÀ¸·Î ÀÎÇÑ PAD ȯÀÚÀÇ ±ÞÁõÀº °³º¹ Ç÷°ü ¼ö¼ú¿¡ µû¸¥ ÇÕº´Áõ°ú ȸº¹ ½Ã°£À» ÇÇÇÒ ¼ö ÀÖ´Â Ä«Å×ÅÍ ±â¹Ý Ç÷°ü Àç°Ç¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ºÎÃß±â°í ÀÖ½À´Ï´Ù. Ç÷°ü ³» Ä¡·á´Â ´ëÅ𵿸Æ, ¿ä°ñµ¿¸Æ ¶Ç´Â Æä´Þ Á¢±ÙÀ» ÅëÇØ À¯µµµÇ´Â ¾ãÀº ±â±¸¸¦ »ç¿ëÇÏ¿© Ç÷°ü È®Àå, ÇöóÅ© Á¦°Å, Ç÷ÀüÁ¦°Å°¡ °¡´ÉÇÕ´Ï´Ù. Á¶±â Ç÷°ü Áúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÁßÁõ ÇãÇ÷¼º ÇÏÁö(CLI) ¹× Á¶Á÷ ¼Õ½ÇÀÌ ½ÃÀ۵DZâ Àü¿¡ ¸»ÃÊ ÁßÀç½Ã¼úÀ» ÅëÇØ Àû±ØÀûÀ¸·Î Ä¡·á¹Þ´Â ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Á¤¸Æ ¿ª·ùÁõ, °ñ¹Ý ³» ¿ïÇ÷ ÁõÈıº, Åõ¼® Á¢±Ù ±â´É Àå¾Ö¿Í °°Àº ºñµ¿¸Æ°æÈ­¼º Ç÷°ü Áúȯµµ ¸»ÃÊ ½Ã¼úÀ» ÅëÇØ °ü¸®µÇ°í ÀÖ½À´Ï´Ù. ÇÏÀ̺긮µå Ç÷°ü ¼ö¼ú½Ç, ¿Ü·¡ ±â¹Ý °Ë»ç½Ç(OBL), ÁßÀçÀû ¿µ»óÀÇÇнÇÀÇ Áõ°¡·Î ´õ ¸¹Àº ½Ã¼ú Á¢±Ù°ú ´çÀÏ Åð¿ø °æ·Î°¡ °¡´ÉÇØÁö°í ÀÖ½À´Ï´Ù. °¡Ä¡ ±â¹Ý Ç÷°ü Ä¡·á ¸ðµ¨·ÎÀÇ ÀüȯÀº º¸´Ù ÃÖ¼Òħ½ÀÀûÀ̰í, ºñ¿ë È¿À²ÀûÀ̸ç, Ä¡·á °á°ú°¡ ÃÖÀûÈ­µÈ ÁßÀçÀû Ä¡·áÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÀåºñÀÇ Çõ½Å°ú ¿µ»ó ±â¼úÀº ¾î¶»°Ô Ä¡·á °á°ú¸¦ ÀçÁ¤ÀÇÇϰí Àִ°¡?

ÀåÄ¡ÀÇ ¼ÒÇüÈ­, °¡À̵å¿ÍÀÌ¾î ±â¼úÀÇ Çâ»ó, Ä«Å×ÅÍÀÇ Á¶ÀÛ¼º Çâ»óÀº ¸»ÃÊ ÁßÀç½Ã¼ú¿¡ Çõ¸íÀ» °¡Á®¿Ô½À´Ï´Ù. ¾à¹° ÄÚÆÃ Ç³¼±(DCB)°ú ¾à¹° ¿ëÃâ ½ºÅÙÆ®(DES)´Â ´ëÅð ½½°³°ñ ¹× ½½°³°ñ ÇϺΠÀçÇùÂø·üÀ» °¨¼Ò½ÃÄ×½À´Ï´Ù. ȸÀü½Ä, ±Ëµµ½Ä, ·¹ÀÌÀú½Ä, ¹æÇ⼺ µî ´Ù¾çÇÑ Á×Á¾ ÀýÁ¦ ±â±â´Â ƯÁ¤ º´º¯ ÇüÅÂ¿Í ¼®È¸È­ ÆÐÅÏ¿¡ ¸Â°Ô Á¶Á¤µÇ¾î º¹ÀâÇÑ PAD¿¡¼­ ÇöóÅ© Á¦°Å ¹× Ç÷°ü Áغñ¸¦ °³¼±ÇÕ´Ï´Ù.

IVUS(Ç÷°ü³» ÃÊÀ½ÆÄ), OCT(ºû °£¼· ´ÜÃþÃÔ¿µ)¿Í °°Àº ÃÊÀ½ÆÄ ¹× Ç÷°ü ³» ¿µ»ó ±â¹ýÀº º´º¯ÀÇ Æ¯Â¡À» Æò°¡Çϰí, ÀåÄ¡ÀÇ Å©±â¸¦ °áÁ¤Çϸç, ½Ã¼ú ÈÄ °á°ú¸¦ ½Ç½Ã°£À¸·Î Æò°¡Çϱâ À§ÇØ ÇöÀç µµÀԵǰí ÀÖ½À´Ï´Ù. 3D Ç÷°ü ³»ºñ°ÔÀ̼ǰú ·Îº¿ Ä«Å×Å͵µ ½Ã¼úÀÇ Á¦¾î¿Í ÀçÇö¼ºÀ» ³ôÀ̱â À§ÇØ Å×½ºÆ®µÇ°í ÀÖ½À´Ï´Ù. »öÀü ¹æÁö ÀåÄ¡¿Í Ç÷°ü Æó¼â ½Ã½ºÅÛÀº À§Çèµµ°¡ ³ôÀº ½Ã¼ú¿¡¼­ ¾ÈÀü ¸¶ÁøÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

Á¤¸Æ ÁßÀç¼ú¿¡¼­ ·¹ÀÌÀú¿Í °íÁÖÆÄ ÀýÁ¦ Ä«Å×ÅÍ´Â Á¤¸Æ·ù Ä¡·áÀÇ ¿Ü°úÀû Á¦°Å¸¦ ´ëüÇÏ¿© ´õ ºü¸¥ ȸº¹°ú Àç¹ß °¨¼Ò¸¦ ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. DVT³ª Æó»öÀüÁõ¿¡¼­ ÈíÀÔ Ä«Å×Åͳª ȸÀü ¹Ù½ºÄϰú °°Àº ±â°èÀû Ç÷ÀüÁ¦°Å ½Ã½ºÅÛÀ» ÅëÇØ Àü½Å Ç÷Àü¿ëÇØÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê°íµµ Ç÷ÀüÀ» Á¦°ÅÇÒ ¼ö ÀÖ¾î ÃâÇ÷ÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ºñ°è Àç·á, »ýºÐÇØ¼º ½ºÅÙÆ®, ½Ã½º·ç ½Ã½ºÅÛÀÇ Çõ½Å ¶ÇÇÑ ¸»ÃÊ Ä¡·áÀÇ ÇØºÎÇÐÀû ¹üÀ§¿Í ³»±¸¼ºÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù.

¸»ÃÊÁßÀç¼úÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ÀÓ»ó ºÐ¾ß¿Í Áö¿ª ½ÃÀåÀº?

¸»ÃÊÁßÀç¼úÀº ÁßÀçÀû ½ÉÀåÇÐ, ÁßÀçÀû ¿µ»óÀÇÇÐ, Ç÷°ü¿Ü°ú, ½ÅÀå³»°ú µî ´Ù¾çÇÑ Àü¹®ºÐ¾ß¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. °¡Àå Å« ÀÓ»óÀû ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ´Â ºÐ¾ß´Â PAD °ü¸®, ƯÈ÷ ´ç´¢º´°ú ½ÅÀå ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀ» À§ÇÑ ¹«¸­ ¾Æ·¡(BTK) ÁßÀç¼úÀÔ´Ï´Ù. Ư¼öÇÑ ±³Â÷ ±â±¸¿Í ¾ãÀº dz¼±À» ÅëÇØ Àå½Ã°£ ¼®È¸È­ º´º¯ÀÇ Ç÷Çà Àç°Ç°ú ¸¸¼º ¿ÏÀü Æó»ö(CTO) Ä¡·á°¡ ´õ¿í ½ÇÇö °¡´ÉÇØÁ³½À´Ï´Ù.

Åõ¼® Á¢±Ù ºÎ¹® ¿ª½Ã ¼ºÀåÇϰí ÀÖ´Â Æ´»õ ºÐ¾ß·Î µ¿Á¤¸Æ·ç(AVF)ÀÇ ÇùÂøÀ» dz¼±Ç÷°ü¼ºÇü¼ú, ½ºÅÙÆ® À̽ļú, Ç÷ÀüÁ¦°Å¼ú µîÀ¸·Î Ä¡·áÇÏ¿© Ç÷·ù¸¦ ȸº¹Çϰí Á¢±Ù¼ºÀ» ¿¬Àå½ÃŰ´Â Ä¡·á¹ýÀÔ´Ï´Ù. Á¤¸Æ ¿ª·ù, °ñ¹ÝÁ¤¸Æ ºÎÀü, Ç÷Àü ÈÄ ÁõÈıº¿¡ ´ëÇÑ Á¤¸Æ ³» ÁßÀç¼úµµ »õ·Î¿î »öÀü ÄÚÀÏ, Á¢ÂøÁ¦, °æÈ­Á¦¸¦ »ç¿ëÇÏ¿© È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀڱñÙÁ¾ »öÀü¼ú°ú Àü¸³¼± µ¿¸Æ »öÀü¼úÀº »ý½ÄÀÇÇÐ ºÐ¾ß¿¡¼­ ¼ö¼úÀÇ ´ë¾ÈÀ¸·Î ºñÁ¾¾çÇÐÀû, ÃÖ¼Òħ½ÀÀû Ä¡·á¹ýÀÔ´Ï´Ù.

Áö¸®ÀûÀ¸·Î´Â ºÏ¹Ì°¡ Áö¹èÀûÀε¥, ±× ÀÌÀ¯´Â ½Ã¼ú °Ç¼ö, źźÇÑ ÁßÀçÀû ÀÎÇÁ¶ó, Æø³ÐÀº »óȯ ¹üÀ§¿¡ ±âÀÎÇÕ´Ï´Ù. À¯·´Àº °³º°È­µÈ Ç÷°ü Ä¡·á °æ·Î¿Í DCB ¹× Á׻󵿸ưæÈ­Áõ Ä¡·á ½Ã½ºÅÛ µµÀÔ¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç, ƯÈ÷ Áß±¹°ú Àεµ´Â Ç÷°ü Áúȯ ºÎ´ã Áõ°¡, Ä«Å×ÅÍ »ðÀÔ¼ú º¸±Þ·ü Áõ°¡, ÁßÀç½Ã¼ú ÈÆ·ÃÀÇ È®´ë·Î ÀÎÇØ Æø¹ßÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Áßµ¿ ¹× Áß³²¹Ì ½ÃÀå¿¡¼­´Â °ø°ø ¹× ¹Î°£ÀÇ ÇコÄɾî ÅõÀÚ¸¦ ÅëÇØ ¸»ÃÊÀû °³ÀÔÀÌ Á¡Â÷ µµÀԵǰí ÀÖ½À´Ï´Ù.

¼¼°è ¸»ÃÊÁßÀç ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

¼¼°è ¸»ÃÊÇ÷°ü ÁßÀç½Ã¼ú ½ÃÀåÀÇ ¼ºÀåÀº ¸»ÃÊÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡, ºü¸¥ ±â¼ú Çõ½Å, ÃÖ¼Òħ½ÀÀû Ä¡·áÀÇ Ã¤Åà Áõ°¡, ¿Ü·¡È¯ÀÚ ¹× ¿¹¹æÀû Ç÷°ü Ä¡·á·Î ÀüȯÇÏ´Â ¼¼°è Ãß¼¼¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °í·ÉÈ­¿Í ´ç´¢º´ ȯÀÚÀÇ ¸¸¼º Ç÷°üÁúȯ ºÎ´ãÀÌ Áõ°¡ÇÏ´Â »óȲ¿¡¼­ ¸»ÃÊÁßÀç¼úÀº È¿°úÀûÀ̰í È¿À²ÀûÀÎ Ä¡·á ÆÐ·¯´ÙÀÓÀ» Á¦°øÇÕ´Ï´Ù.

Â÷¼¼´ë DCB, ½ºÅÙÆ® Ç÷§Æû, »öÀüÁ¦¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ¸·Î ½Ã¼úÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí, º¸Çè »óȯ Á¤Ã¥, ¿Ü·¡ ¼¾ÅÍ¿¡¼­ÀÇ Ç÷°ü ³» Ä¡·áÀÇ ÅëÇÕ, Àü¹® ºÐ¾ß¸¦ ³Ñ¾î¼± ±³À° °­È­´Â ½Ã¼úÀÇ ¹üÀ§¿Í ¼ö¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ºñ¼ö¼úÀû ÁßÀç¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¼±È£µµ´Â Àå±âÀûÀÎ °á°ú °³¼±°ú ÇÕº´Áõ À§Çè °¨¼Ò¿Í ÇÔ²² ½ÃÀåÀÇ ¸ð¸àÅÒÀ» ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù.

Ç÷°üÄ¡·á°¡ µ¥ÀÌÅÍ ±â¹ÝÀÇ °á°ú Áß½ÉÀÇ Àü¹® ºÐ¾ß·Î ÁøÈ­ÇÔ¿¡ µû¶ó ¸»ÃÊÁßÀç¼úÀº °è¼ÓÇØ¼­ Ä¡·áÀÇ ÇÙ½ÉÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀÌ »çÁö º¸Á¸, ½ÉÇ÷°ü À§Çè °¨¼Ò, ÃÖ¼Òħ½ÀÀû Áúº´ °ü¸® Àü·«À» ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÉ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.

ºÎ¹®

ÀÎÅͺ¥¼Ç Á¾·ù(¾ÆÅ×·ºÅä¹Ì ÀÎÅͺ¥¼Ç, ½ºÅÙÆ® À¯Ä¡ ÀÎÅͺ¥¼Ç, Ç÷°ü¼ºÇü ÀÎÅͺ¥¼Ç, Ç÷ÀüÁ¦°Å ÀÎÅͺ¥¼Ç, »öÀü ÀÎÅͺ¥¼Ç), µð¹ÙÀ̽º Á¾·ù(ÀÎÅͺ¥¼Ç Ä«Å×ÅÍ, ÀÎÅͺ¥¼Ç ½ºÅÙÆ®, °¡À̵å¿ÍÀ̾î, ÀÎÅͺ¥¼Ç dz¼±, »öÀü ÄÚÀÏ), ÀûÀÀÁõ(°ü»óµ¿¸ÆÁúȯ ÀûÀÀÁõ, ³úÁ¹Áß ÀûÀÀÁõ, ¸»Ãʵ¿¸ÆÁúȯ ÀûÀÀÁõ, ½Åµ¿¸Æ ÇùÂø ÀûÀÀÁõ, °æµ¿¸Æ ÇùÂø ÀûÀÀÁõ), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, Á¶»ç±â°ü ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Peripheral Interventions Market to Reach US$16.3 Billion by 2030

The global market for Peripheral Interventions estimated at US$10.8 Billion in the year 2024, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Atherectomy Intervention, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$6.5 Billion by the end of the analysis period. Growth in the Stent Implantation Intervention segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 10.9% CAGR

The Peripheral Interventions market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Peripheral Interventions Market - Key Trends & Drivers Summarized

Why Are Peripheral Interventions Gaining Traction in Modern Vascular Therapy?

Peripheral interventions-minimally invasive procedures that treat blockages or abnormalities in blood vessels outside the heart and brain-are becoming an integral part of vascular care as chronic vascular diseases escalate globally. These interventions encompass procedures such as angioplasty, stenting, atherectomy, thrombectomy, embolization, and endovenous ablation. They are employed to manage peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, aneurysms, and arteriovenous malformations.

The surge in PAD cases, attributed to aging populations, diabetes, smoking, and sedentary lifestyles, is fueling demand for catheter-based revascularization techniques that avoid the complications and recovery times associated with open vascular surgery. Endovascular therapy allows for vessel dilation, plaque removal, or clot extraction using low-profile devices guided via femoral, radial, or pedal access. As awareness about early-stage vascular disease improves, more patients are being treated proactively using peripheral intervention before the onset of critical limb ischemia (CLI) or tissue loss.

Non-atherosclerotic vascular conditions such as venous reflux disease, pelvic congestion syndrome, and dialysis access dysfunction are also being increasingly managed using peripheral techniques. The growth of hybrid vascular ORs, outpatient-based labs (OBLs), and interventional radiology suites is enabling greater procedural access and same-day discharge pathways. The shift toward value-based vascular care models is reinforcing the importance of less invasive, cost-effective, and outcome-optimized interventional therapies.

How Are Device Innovations and Imaging Technologies Redefining Outcomes?

Device miniaturization, improved guidewire technology, and enhanced catheter maneuverability have revolutionized peripheral interventions. Drug-coated balloons (DCBs) and drug-eluting stents (DES) have reduced restenosis rates in femoropopliteal and infrapopliteal segments. Atherectomy devices-rotational, orbital, laser, or directional-are being tailored to specific lesion morphologies and calcification patterns, improving plaque debulking and vessel preparation in complex PAD.

Ultrasound and intravascular imaging modalities such as IVUS (intravascular ultrasound) and OCT (optical coherence tomography) are now being deployed to assess lesion characteristics, guide device sizing, and evaluate post-procedural outcomes in real-time. 3D vascular navigation and robotic catheters are also being tested for enhanced procedural control and reproducibility. Embolic protection devices and vessel closure systems are increasing safety margins in high-risk procedures.

In venous interventions, laser and radiofrequency ablation catheters are replacing surgical stripping for varicose vein treatment, providing faster recovery and reduced recurrence. For DVT and pulmonary embolism, mechanical thrombectomy systems like aspiration catheters and rotating baskets are allowing for clot removal without systemic thrombolytics, reducing bleeding risks. Innovations in scaffold materials, biodegradable stents, and sheathless systems are also expanding the anatomical reach and durability of peripheral therapies.

Which Clinical Segments and Regional Markets Are Leading Peripheral Interventional Growth?

Peripheral interventions span a wide range of specialties including interventional cardiology, interventional radiology, vascular surgery, and nephrology. The most significant clinical growth is occurring in PAD management, especially in below-the-knee (BTK) interventions for patients with diabetes or renal disease. Revascularization of long, calcified lesions and treatment of chronic total occlusions (CTOs) are becoming more feasible with specialty crossing devices and low-profile balloons.

The dialysis access segment is another growing niche, where arteriovenous fistula (AVF) stenoses are treated using balloon angioplasty, stent grafts, or thrombectomy to restore flow and preserve access longevity. Endovenous interventions for venous reflux, pelvic venous insufficiency, and post-thrombotic syndrome are also expanding with new embolization coils, adhesives, and sclerosants. Uterine fibroid embolization and prostate artery embolization represent non-oncologic, minimally invasive alternatives to surgery in the reproductive health domain.

Geographically, North America dominates due to high procedural volumes, robust interventional infrastructure, and wide reimbursement coverage. Europe is focused on personalized vascular care pathways and adoption of DCBs and atherectomy systems. Asia-Pacific, particularly China and India, is seeing explosive growth due to rising vascular disease burden, increasing cath lab penetration, and expanding interventional training. Middle Eastern and Latin American markets are gradually adopting peripheral interventions through public-private healthcare investments.

What Is Driving Growth in the Global Peripheral Interventions Market?

The growth in the global peripheral interventions market is driven by the rising prevalence of peripheral vascular disease, rapid technology innovation, increasing adoption of minimally invasive therapies, and the global shift toward outpatient and preventive vascular care. As the burden of chronic vascular conditions rises, particularly in aging and diabetic populations, peripheral interventions offer an effective and efficient treatment paradigm.

Regulatory approvals for newer-generation DCBs, stent platforms, and embolic agents are accelerating procedural adoption. Meanwhile, supportive reimbursement policies, integration of endovascular procedures in outpatient centers, and enhanced cross-specialty training are expanding procedural reach and acceptance. Patient preference for non-surgical interventions, combined with improved long-term outcomes and lower complication risks, further strengthens market momentum.

As vascular care evolves into a data-driven, outcome-focused specialty, peripheral interventions will remain a cornerstone of therapy. The market is poised for continued expansion as healthcare systems prioritize limb preservation, cardiovascular risk reduction, and minimally invasive disease management strategies.

SCOPE OF STUDY:

The report analyzes the Peripheral Interventions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Intervention Type (Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention, Embolization Intervention); Device Type (Interventional Catheters, Interventional Stents, Guide Wires, Interventional Balloons, Embolic Coils); Indication (Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication, Carotid Artery Stenosis Indication); End-User (Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User, Research Institutes End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â